Role of cadherins in cancer—a review
I Kaszak, O Witkowska-Piłaszewicz… - International journal of …, 2020 - mdpi.com
Cadherins play an important role in tissue homeostasis, as they are responsible for cell-cell
adhesion during embryogenesis, tissue morphogenesis, differentiation and carcinogenesis …
adhesion during embryogenesis, tissue morphogenesis, differentiation and carcinogenesis …
Heterogeneity and plasticity of epithelial–mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms
D Li, L **a, P Huang, Z Wang, Q Guo, C Huang… - Cell …, 2023 - Wiley Online Library
Epithelial–mesenchymal transition (EMT) or mesenchymal–epithelial transition (MET) plays
critical roles in cancer metastasis. Recent studies, especially those based on single‐cell …
critical roles in cancer metastasis. Recent studies, especially those based on single‐cell …
Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway
S Chen, Y Morine, K Tokuda… - International …, 2021 - spandidos-publications.com
Targeting the tumor stroma is an important strategy in cancer treatment. Cancer‑associated
fibroblasts (CAFs) and tumor‑associated macrophages (TAMs) are two main components in …
fibroblasts (CAFs) and tumor‑associated macrophages (TAMs) are two main components in …
LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b
Y Fan, W Sheng, Y Meng, Y Cao… - … cells, nanomedicine, and …, 2020 - Taylor & Francis
LncRNA PTENP1 is a competitive endogenous RNA (ceRNA) involved in decoying miR-
106b in multiple diseases. This study investigates the interaction of PTENP1 and miR-106b …
106b in multiple diseases. This study investigates the interaction of PTENP1 and miR-106b …
Novel regulation of miR‐34a‐5p and HOTAIR by the combination of berberine and gefitinib leading to inhibition of EMT in human lung cancer
F Zheng, J Li, CJ Ma, XJ Tang, Q Tang… - Journal of cellular …, 2020 - Wiley Online Library
HOTAIR is an important carcinogenic lncRNA and involves in tumorigenesis, and invasion.
MiR‐34a‐5p functions as a tumour suppressor. However, the underlying mechanism of …
MiR‐34a‐5p functions as a tumour suppressor. However, the underlying mechanism of …
Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells
Cholangiocarcinoma (CCA), the cancer arising from the epithelial cells of bile ducts, is a
prototype of inflammatory-driven cancer. Cytokines released by cancer associated …
prototype of inflammatory-driven cancer. Cytokines released by cancer associated …
N-cadherin targeted melanin nanoparticles reverse the endothelial–mesenchymal transition in vascular endothelial cells to potentially slow the progression of …
Endothelial–mesenchymal transition (EndoMT) of vascular endothelial cells has recently
been considered as a key player in the early progression of a variety of vascular and …
been considered as a key player in the early progression of a variety of vascular and …
ITGA3 interacts with VASP to regulate stemness and epithelial-mesenchymal transition of breast cancer cells
H Zhang, X Cui, X Li, L Li - Gene, 2020 - Elsevier
Background The interaction of integrin and extracellular matrix (ECM) has a profound
implication on pathological conditions such as tumor growth and infiltration. Related reports …
implication on pathological conditions such as tumor growth and infiltration. Related reports …
miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells
Epithelial-mesenchymal transition (EMT) symbolizes the predominant program of advanced-
stage cancer, it is critical in cancer progression, metastasis, and chemotherapy resistance. In …
stage cancer, it is critical in cancer progression, metastasis, and chemotherapy resistance. In …
Induced tamoxifen resistance is mediated by increased methylation of E-cadherin in estrogen receptor-expressing breast cancer cells
Q Wang, M Gun, X Hong - Scientific reports, 2019 - nature.com
Estrogen receptor-positive breast cancers are treated with tamoxifen, a drug that
competitively inhibits the binding of estrogen to its receptor. Resistance to tamoxifen is a …
competitively inhibits the binding of estrogen to its receptor. Resistance to tamoxifen is a …